Doctors altered a person’s genes with CRISPR for the first time in the U.S. Here’s what could be next. By Donavyn Coffey
Scientists ‘went rogue’ and genetically engineered two human babies—or at least claimed to By Kat Eschner
Stem Cells Scientists can now swap out bad spinal discs with lab-grown alternatives—at least in goats By Kat Eschner
Vaccines Meningitis shot that fights 5 different strains shows promise in latest trial By Laura Baisas
Vaccines White House invests $5 billion in new COVID vaccines and treatments as national emergency ends By Laura Baisas
It’s easier than ever to make DNA from scratch—but what are the risks? By Michael Schulson/Undark / Dec 22, 2022
A genetics startup wants to bring the Tasmanian tiger back from extinction By Laura Baisas / Aug 17, 2022
The first US trial to release GMO mosquitoes just ended. Here’s how it went. By Hannah Seo / Apr 20, 2022
A ‘living’ cancer drug helped two patients stay disease-free for a decade By Kate Baggaley / Feb 17, 2022
This CRISPR startup thinks that mammoths can save the Arctic. Is it right? By Charlotte Hu / Sep 13, 2021
These gene-edited tomatoes grow in cute little bouquets suited to urban farming By Kat Eschner / Dec 24, 2019
Doctors altered a person’s genes with CRISPR for the first time in the U.S. Here’s what could be next. By Donavyn Coffey / Aug 8, 2019